New therapeutic approaches based on gene transfer techniques

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

It is evident that the vectors in current use are not ideal for in vivo gene delivery, especially for the targeted transfer of exogenous genes to multifocal metastatic lesions. In view of the insufficiently high titres of current viral vectors it is therefore almost obligatory to employ therapeutic genes whose products would produce an effect even when only a small proportion of the target cells express the gene. Currently, most of the work involving viral vectors has employed replication-defective viruses. However, there are persuasive reasons to consider the use of replication-competent viruses for in vivo gene transfer, where the therapeutic gene would then be transmissable to other cells, resulting in amplification of the number of cells expressing the transgene [98]. Such an approach would absolutely require reliable strategies to target the vectors to the tumour cells or to target transgene expression.

Original languageEnglish (US)
Pages (from-to)149-170
Number of pages22
JournalSpringer Seminars in Immunopathology
Volume18
Issue number2
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Gene Transfer Techniques
Genes
Transgenes
Therapeutics
Defective Viruses
Virus Replication
Cell Count
Neoplasms

ASJC Scopus subject areas

  • Immunology

Cite this

New therapeutic approaches based on gene transfer techniques. / Chong, Heung; Vile, Richard Geoffrey.

In: Springer Seminars in Immunopathology, Vol. 18, No. 2, 1996, p. 149-170.

Research output: Contribution to journalArticle

@article{5ef8d362d73940aeb7b613dee434aa5e,
title = "New therapeutic approaches based on gene transfer techniques",
abstract = "It is evident that the vectors in current use are not ideal for in vivo gene delivery, especially for the targeted transfer of exogenous genes to multifocal metastatic lesions. In view of the insufficiently high titres of current viral vectors it is therefore almost obligatory to employ therapeutic genes whose products would produce an effect even when only a small proportion of the target cells express the gene. Currently, most of the work involving viral vectors has employed replication-defective viruses. However, there are persuasive reasons to consider the use of replication-competent viruses for in vivo gene transfer, where the therapeutic gene would then be transmissable to other cells, resulting in amplification of the number of cells expressing the transgene [98]. Such an approach would absolutely require reliable strategies to target the vectors to the tumour cells or to target transgene expression.",
author = "Heung Chong and Vile, {Richard Geoffrey}",
year = "1996",
doi = "10.1007/BF00820663",
language = "English (US)",
volume = "18",
pages = "149--170",
journal = "Seminars in Immunopathology",
issn = "1863-2297",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - New therapeutic approaches based on gene transfer techniques

AU - Chong, Heung

AU - Vile, Richard Geoffrey

PY - 1996

Y1 - 1996

N2 - It is evident that the vectors in current use are not ideal for in vivo gene delivery, especially for the targeted transfer of exogenous genes to multifocal metastatic lesions. In view of the insufficiently high titres of current viral vectors it is therefore almost obligatory to employ therapeutic genes whose products would produce an effect even when only a small proportion of the target cells express the gene. Currently, most of the work involving viral vectors has employed replication-defective viruses. However, there are persuasive reasons to consider the use of replication-competent viruses for in vivo gene transfer, where the therapeutic gene would then be transmissable to other cells, resulting in amplification of the number of cells expressing the transgene [98]. Such an approach would absolutely require reliable strategies to target the vectors to the tumour cells or to target transgene expression.

AB - It is evident that the vectors in current use are not ideal for in vivo gene delivery, especially for the targeted transfer of exogenous genes to multifocal metastatic lesions. In view of the insufficiently high titres of current viral vectors it is therefore almost obligatory to employ therapeutic genes whose products would produce an effect even when only a small proportion of the target cells express the gene. Currently, most of the work involving viral vectors has employed replication-defective viruses. However, there are persuasive reasons to consider the use of replication-competent viruses for in vivo gene transfer, where the therapeutic gene would then be transmissable to other cells, resulting in amplification of the number of cells expressing the transgene [98]. Such an approach would absolutely require reliable strategies to target the vectors to the tumour cells or to target transgene expression.

UR - http://www.scopus.com/inward/record.url?scp=0029812648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029812648&partnerID=8YFLogxK

U2 - 10.1007/BF00820663

DO - 10.1007/BF00820663

M3 - Article

C2 - 8908697

AN - SCOPUS:0029812648

VL - 18

SP - 149

EP - 170

JO - Seminars in Immunopathology

JF - Seminars in Immunopathology

SN - 1863-2297

IS - 2

ER -